PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
01-Feb-2023 Glaukos to Release Fourth Quarter and Full Year 2022 Financial Results after Market Close on February 22 Businesswire
01-Feb-2023 BeiGene to Present at Upcoming Investor Conferences Businesswire
01-Feb-2023 Bausch + Lomb and Modulight Announce FDA Approval of ML6710i Photodynamic Laser for Use with Bausch + Lomb’s VISUDYNE® (Verteporfin for Injection) Businesswire
01-Feb-2023 Adicet Bio to Participate in a Fireside Chat at the 2023 Guggenheim Oncology Conference Businesswire
01-Feb-2023 Global TIL Therapies Market Report 2023 to 2035: Key Players Include Bristol-Myers Squibb, CAR-T (Shanghai) Cell Biotechnology, Cellectis and Incyte - ResearchAndMarkets.com Businesswire
01-Feb-2023 AmerisourceBergen Reports Fiscal 2023 First Quarter Results Businesswire
01-Feb-2023 Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2022 Results Businesswire
01-Feb-2023 Launch of LighthouseAI, an AI-Based Venture Unit to Solve Commercial Regulatory Compliance for the Life Sciences Industry Newswire
01-Feb-2023 Global and Regional Next-Generation Sequencing (NGS) Informatics Market Report 2022-2032: Burgeoning Opportunities in the Evolving Regulatory Landscape for Clinical NGS - ResearchAndMarkets.com Businesswire
01-Feb-2023 Ellipses Pharma Announces FDA Approval of IND Application for EP0042 for Patients With Acute Myeloid Leukaemia Businesswire
01-Feb-2023 Unimed Procurement Services received Queen’s Award for Enterprise in prestigious presentation ceremony Unimed Procurement Services
01-Feb-2023 Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Businesswire
31-Jan-2023 Envision Pharma Group Hires Leading Industry Executives Dominic Marasco and Gregory Carpenter to Lead Further Expansion of the Business and Support Growing Customer Demand Newswire
26-Jan-2023 Cherwell publishes new guide to EM best practice in compliance with revised Annex 1 Cherwell Laboratories
26-Jan-2023 Future of clinical research in the NHS in jeopardy without urgent action, warns Lords Committee House of Lords
26-Jan-2023 Almac Group Opens Registration for Internationally Recognised Process Chemistry Forum in Belfast Almac Group
26-Jan-2023 Douglas Pharmaceuticals Announces Formation of Clinical Advisory Board for Lead Program R-107 Douglas Pharmaceuticals
26-Jan-2023 ONXEO provides update on the Development Program for its first-in-class drug candidate AsiDNATM Onxeo
26-Jan-2023 Orbsen Therapeutics announces encouraging interim results from the NEPHSTROM proof of concept clinical study evaluating ORBCEL™ cell therapy in patients with diabetes and advanced chronic kidney disease Orbsen Therapeutics Limited
26-Jan-2023 Another Clinical Asset Using ProBioGen's GlymaxX® Technology Begins Phase III Novartis